Ayurveda practitioner served warning by BMCRI for allegedly making false claims on COVID cure
Bengaluru: Coming down heavily on an Ayurvedic practitioner, the ethics committee of the Bangalore Medical College and Research Institute (BMCRI) has issued a notice to the practitioner clarifying on the efficacy of his Covid-19 drug or the ongoing clinical trial of the drug might be suspended.
The Ayurvedic doctor is identified as Dr Giridhara Kaje, who was the principal investigator at Prashanthi ayurvedic centre in Rajajinagar. He introduced two tablets called Bhoumya and Sathmya which are going through clinical trials at Victoria Hospital to see if the tablets are effective in curing COVID positive patients.
Meanwhile, the BMCRI ethics committee received information that the doctor is allegedly claiming that the tablets have already passed the clinical trials. Following the same, that committee warned the Ayurveda practitioner that they might suspend the trial process of the tablets.
In the backdrop, the BMCRI was approached by the Ayurveda practitioner for the clinical trial "to evaluate the efficiency and safety of tablet Bhoumya and Sathmya in an add-on therapy to standard of care in COVID-19 positive patients."
In its letter, the BMCRI clarified that the doctor was already aware of the fact that the trials are not over and he knew that the success of the trials has not been confirmed by the ethics committee of BMCRI, yet the doctor has made public claims regarding the beneficial outcomes of the tablets.
Taking serious note of the act during such serious circumstances, the BMCRI reprimanded the doctor as the notice read;
"This is unacceptable and amounts to overstepping of one's responsibility. You are aware that any disclosure of such sensitive information will have to be with all clearances from various appropriate authorities. The above act is viewed seriously since the information is very sensitive in the present circumstance,"
The notice further called upon the doctor stating that if the doctor doesn't present a clarification before the committee, they will be compelled to suspend the trials due to the doctor's "unauthorized act of misleading the public."
